Medicine Recalled
- All
- News
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Indian Medicine Firm Pulls Heart Drug From US Amid Cancer Risk Probes
A unit of India's Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.
-
Samsung Galaxy Note 7 Recall: Samsung Suffers Backlash in China Over Response
Chinese consumers are unusually alert to safety issues following an avalanche of scandals over shoddy or fake food, medicines and other goods.
-
UK says Mylan Recalls Batches of Indian-Made Antibiotic
The Medicines and Healthcare products Regulatory Agency, or MHRA, said the decision was due to the potential for small particles of white material to be present in individual vials.
-
Ranbaxy Recalls Nearly 30,000 Packs of Allergy-Relief Drug in US
The drugmaker started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.
-
Unease grows among US doctors over Indian medicines
India supplies about 40 per cent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada.
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
UK health regulator initiates recall of 5 Wockhardt drugs
The Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday initiated recall of five prescription medicines of India's Wockhardt, following manufacturing deficiencies identified during an inspection of the company's site in Chikalthana in Maharashtra.
-
British drug regulator recalls Wockhardt medicines
Britain's drugs regulator MHRA on Thursday said it would withdraw some medicines made by Wockhardt Ltd after it identified deficiencies in manufacturing procedures at Wockhardt's Waluj site in India.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Indian Medicine Firm Pulls Heart Drug From US Amid Cancer Risk Probes
A unit of India's Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.
-
Samsung Galaxy Note 7 Recall: Samsung Suffers Backlash in China Over Response
Chinese consumers are unusually alert to safety issues following an avalanche of scandals over shoddy or fake food, medicines and other goods.
-
UK says Mylan Recalls Batches of Indian-Made Antibiotic
The Medicines and Healthcare products Regulatory Agency, or MHRA, said the decision was due to the potential for small particles of white material to be present in individual vials.
-
Ranbaxy Recalls Nearly 30,000 Packs of Allergy-Relief Drug in US
The drugmaker started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.
-
Unease grows among US doctors over Indian medicines
India supplies about 40 per cent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada.
-
Unease grows among US doctors over quality of Indian medicines
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration (FDA).
-
UK health regulator initiates recall of 5 Wockhardt drugs
The Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday initiated recall of five prescription medicines of India's Wockhardt, following manufacturing deficiencies identified during an inspection of the company's site in Chikalthana in Maharashtra.
-
British drug regulator recalls Wockhardt medicines
Britain's drugs regulator MHRA on Thursday said it would withdraw some medicines made by Wockhardt Ltd after it identified deficiencies in manufacturing procedures at Wockhardt's Waluj site in India.
